Podcast Index
Browse podcasts by category, open recent episodes, and download audio to listen offline.
BioSpace
BioSpace
Spiritual Tools for an Outrageous World
David Sacks
Youtube Passive Income by Ranking
Master Passive Income Network
リセマム 最新教育情報
株式会社イード
Camaradas Investidores
Borja on Stocks
Badlands Media
Badlands Media
Badlands Media
Badlands Media
Extremadura Informativos
Radio Nacional
AppleInsider Podcast
AppleInsider
SBS Bosnian - SBS na bosanskom jeziku
SBS
The Daily Aus
The Daily Aus
SBS Persian - اس بی اس فارسی
SBS
SBS Cantonese - SBS廣東話節目
SBS
Le Journal Imprévisible
Radio classique
Star News Briefing
Star 104.5
Charlotte News Today | 2 Min News | The Daily News Now!
The Daily News Now!
Galway News Today | 2 Min News | The Daily News Now!
The Daily News Now!
Les Matins de France Culture
France Culture
Daf From RBS
R' Mendy Newman
First Print - Votre podcast comics (& BD) préféré !
First Print - Votre podcast comics (& BD) préféré !
New York Rangers News Today | 2 Min News | The Daily News Now!
The Daily News Now!
The Attack Action Podcast
Taylor Morrow
El Reporte Delfino
Delfino.cr
MLB Morning Lineup Podcast
MLB.com
L'angle éco de François Lenglet
RTL
Die Radio Steiermark-Journale
ORF Radio Steiermark
The COB from ausbiz
ausbiz
Duhovna misel
Tadej Sadar
Into The Parabnormal
Jeremy Scott
Face à Face
RMC
Dr. James White on SermonAudio
Dr. James White
Audiocite.net - Livres audio gratuits
audiocite.net
The Podcast of the Lotus Eaters on Odysee
The Podcast of the Lotus Eaters
Crypto News Today | 2 Min News | The Daily News Now!
The Daily News Now!
Moving Markets
Julius Baer
Durham News Today | 2 Min News | The Daily News Now!
The Daily News Now!
BiblioKISS
KISS FM
All
BioSpace
In this episode of Denatured, you’ll hear from Jack Crawford, CEO of Demetra, and Magnus Gustavsson, chief commercial officer at NorthX Biologics. We unpack the evolution of cell line development — CHO cells, targeted in...
A surprising deal from Vertex Pharmaceuticals adds to Big Pharma’s acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for deriske...
The vibe at BIO 2026 in San Diego last week was overwhelmingly positive, with attendees observing noticeable changes at the FDA and an uptick in dealmaking and IPOs. Plus, a top medical journal this week retracted a pivo...
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll hear from Hakan Goker, managing director at M Ventures and Maina Bhaman, partner at Sofinnova Partners. We ex...
This year has been partly defined by a return to M&A. In the first quarter of 2026, biopharma spent nearly $47 billion in acquisitions across 19 deals, and this week, AbbVie notched another one for the second quarter, sc...
In this episode of Denatured, you'll hear from Mark Lowdell, CSO & co-founder at INmuneBio Inc. and Vishwas Seshadri, CEO & director at Abeona Therapeutics. We examine how recessive dystrophic epidermolysis bullosa serve...
Moderna’s mRNA-based flu vaccine made headlines in February when the FDA declined to even review the application. Days later, the agency reversed course, setting a decision date for August and later scheduling an advisor...
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll hear from Hannah Franklin, associate at Biovance Capital and Pablo Gabriel Cironi Lopez, director of life sc...
Everything came up roses for Eli Lilly at the American Diabetes Association, as the pharma boasted positive results for its new pill Foundayo and next-gen asset retatrutide—not just for weight loss but also for other ind...
In this episode of Denatured, you'll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immunology discovery at Eli Lilly. We dive into the long-overlooked hai...
At the American Society of Clinical Oncology (ASCO) annual meeting in Chicago this past weekend, packed plenary sessions from Revolution Medicines and Summit Therapeutics’ Chinese partner Akeso stole the show. For RevMed...
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll be hearing from Ksenija Pavletic, partner and chief commercial officer at Jeito Capital and Thierry Laugel, m...
Eli Lilly has been as acquisitive as ever, striking five new deals in the past week alone. On Tuesday, the company dove into the deep end of vaccine development with three separate buys in the space. Outside of vaccines,...
In this episode of Denatured, as part of our series of the European life science investment ecosystem, you'll be hearing from Regina Hodits, managing director at Angelini Ventures and Sofia Ioannidou, VC partner at Ande...
FDA Commissioner Marty Makary officially resigned last week following reports of his ouster. Then, the acting directors for the agency’s two main review units also left their posts, as did the FDA chief of staff and chie...
In this episode of Denatured, you'll be hearing from Miguel Forte, president of the International Society for Cell and Gene Therapy (ISCT), and John Ellis, co-founder & CEO of Trenchant Bios, speaking live from the ISCT ...
Moments after recording this episode of The Weekly, FDA Commissioner Marty Makary announced his resignation. Reports first circulated last Friday that President Donald Trump had signed off on his ouster. The president in...
In this episode of Denatured, you'll be hearing from Georg Vo Beiske, CEO of Tribune Therapeutics and Jonas Hallén, co-founder & Chief Medical Officer of Calluna Pharma. We dive into IPF and fibrosis challenges, unpackin...
First quarter earnings continue to roll in, with Pfizer, Eli Lilly, Amgen and more reporting in the past week. While Pfizer beat consensus estimates, it wasn’t enough for analysts, who had greater expectations for the Ne...
First quarter earnings continue to roll in, with Pfizer, Eli Lilly, Amgen and more reporting in the past week. While Pfizer beat consensus estimates, it wasn’t enough for analysts, who had greater expectations for the Ne...
Fill in the form below. Make sure to select both Country and Genres.
Send us a message below. We will get back to you within 24 hours.